| Dr Cecily S Whiting, MD | |
|
93 Campus Ave, Lewiston, ME 04240-6030 | |
| (207) 777-8120 | |
| (207) 777-8984 |
| Full Name | Dr Cecily S Whiting |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 93 Campus Ave, Lewiston, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841218104 | NPI | - | NPPES |
| 1841218104 | Medicaid | ME |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 015552 (Maine) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Cecily S Whiting, MD Po Box 1638, Albany, NY 12201-1638 Ph: (207) 777-8208 | Dr Cecily S Whiting, MD 93 Campus Ave, Lewiston, ME 04240-6030 Ph: (207) 777-8120 |
News Archive
The anthrax attacks in the aftermath of September 11, 2001 in the USA have illustrated the high potential of anthrax for misuse in bio-terrorism. Dissemination of anthrax by letters led to the death of 5 people and chemotherapeutic treatment of 30,000 individuals.
Mortality rates after cancer surgery declined for Black as well as white patients during a recent ten-year period, although the mortality gap between the two groups did not narrow, according to new research by Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard University investigators.
Professor Socrates Papapoulos, a long standing member of the IOF Board and leading researcher at the Leiden University Medical Center, has been named the recipient of the prestigious Pierre Delmas Award.
Mady Ohlman was 22 on the evening some years ago when she stood in a friend's bathroom looking down at the sink.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced the initiation of a Phase 2 clinical trial with ACE-031 in patients with Duchenne Muscular Dystrophy (DMD), a fatal neuromuscular disease. ACE-031 is an investigational protein therapeutic that builds muscle and increases strength by inhibiting signaling of a cell surface receptor called the activin receptor type IIB (ActRIIB).
› Verified 1 days ago
Tamara Willoughby, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Main St, Lewiston, ME 04240 Phone: 207-795-5011 Fax: 207-753-7201 | |
William D Collins, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 93 Campus Ave, Lewiston, ME 04240 Phone: 207-777-8120 Fax: 207-777-8984 | |
Dr. Carl Frankthomas Daniel, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 300 Main St, Lewiston, ME 04240 Phone: 207-795-0111 Fax: 207-795-2766 | |
Dr. Sheldon Stevenson, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Main St, Lewiston, ME 04240 Phone: 207-795-0111 | |
Jordan Patrick Maresh, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Main St, Lewiston, ME 04240 Phone: 207-795-0111 | |
Alfred Riel, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 300 Main St, Lewiston, ME 04240 Phone: 207-795-0111 Fax: 207-795-7193 | |
Dr. William Gregorie, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Main St, Lewiston, ME 04240 Phone: 207-795-0111 Fax: 207-795-7193 |